AT & S Austria Technologie & Systemtechnik (ATS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Jun, 2025Executive summary
Revenue for H1 2024/25 declined 2% year-over-year to €800 million, with a net loss of €63 million and EBITDA down 27% to €157 million.
CEO duties assumed by the management board after the chairman stepped down; cost optimization and restructuring, including workforce reduction, are underway.
Expansion projects in Kulim (Malaysia) and Hinterberg/Leoben (Austria) are progressing, with production expected to start in early 2025, though ramp-up is delayed.
Sale of AT&S Korea for €405 million agreed, with closing expected by March 2025 and proceeds to reduce leverage.
Cost-saving initiatives are on track, targeting over €250 million in sustainable savings by next year.
Financial highlights
H1 2024/25 revenue was €800 million, EBITDA margin at 19.6% (adjusted: 27.9%), and net loss of €63 million.
Net debt increased 19% to €1.67 billion, with leverage at 6.7x due to high CapEx and delayed ramp-up.
Cash and equivalents plus unused credit lines at €900 million as of September 30, 2024.
Operating free cash flow was negative at €-345 million, impacted by lower EBITDA and reduced factoring.
Net CAPEX halved year-over-year to €254 million, mainly for Malaysia and Austria projects.
Outlook and guidance
FY 2024/25 revenue guidance revised to €1.5–1.6 billion, with adjusted EBITDA margin of 24–26%.
Net CapEx guidance remains at up to €500 million.
Midterm (FY 2026/27) guidance confirmed: revenue ~€3.0 billion, EBITDA margin 27–32%, ROCE >12%.
High-volume production at new plants delayed, with no revenue contribution expected this year.
Guidance reflects high volatility and low visibility in end markets.
Latest events from AT & S Austria Technologie & Systemtechnik
- Revenue up 10% to €1.314B, EBITDA margin 23%, strong outlook despite FX and supply risks.ATS
Q3 20263 Feb 2026 - Adjusted EBITDA margin rose to 27.6% despite revenue decline and net loss.ATS
Q1 20252 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue, EBITDA, and cash flow improved, but FX and supply chain risks persist.ATS
Q2 202616 Dec 2025 - Revenue up 3%, EBITDA margin at 26%, with major investments and cost savings; outlook cautious.ATS
Q4 202521 Nov 2025 - Revenue up 14.2% year-over-year, but net loss widened on FX and ramp-up costs.ATS
Q1 202616 Nov 2025